Public dataset
Recorded source agreement and disagreement
Show whether sources print one normalized reading, have incompatible units, lack structured comparison context, or contain a context-matched numeric difference.
- Public rows
- 1,681
- Generated
- Schema version
- source-consensus/2
Coverage
What this run contains
- Compared medicine fields
- 1,681
- Agree
- 1,282
- Differ
- 0
- Not comparable
- 12
- Insufficient context
- 387
- Fields represented
- 5
- bioavailability, halfLife, proteinBinding, tMax, volumeOfDistribution
Method
How the rows were made
- Deterministic rules normalize recorded pharmacokinetic readings and compare only like-for-like values.
- One normalized printed reading may be agree even when clinical context was not extracted; this reports printed-reading agreement only.
- Distinct readings may differ only when their units and denominators are comparable and one matching, non-placeholder population/formulation context was structurally extracted. Otherwise they are insufficient_context.
- not_comparable preserves incompatible units or denominators instead of guessing. insufficient_context preserves missing or non-matching structured context instead of manufacturing agreement or disagreement.
- The agreement rate describes the distribution of recorded source readings; it is not a probability that a value is true.
- Every distinct printed reading retains its unit, population context, source count, and complete source records. The API paginates field rows, never child readings or sources.
- documentsExamined is every matching single-substance archive document inspected for that medicine. The generator has no document, reading, or source ceiling, so there is no hidden available-versus-retained remainder.
Limits
Read these before using a row
- Current label parsing does not structurally extract population or formulation context. Distinct otherwise-comparable readings are therefore insufficient_context, never differ; agree may mean printed-reading agreement only. Source records are complete but are not independent-experiment counts.
- The current deterministic parser does not structurally extract population or formulation context from these sentences. It records that context as unknown and cannot publish distinct same-unit readings as differ.
- Neither reading is marked wrong. Population, formulation, route, and other unextracted context may explain the printed difference.
- Only the recorded fields and source documents in this snapshot are compared.
- A source count is the number of retained source records in the row, not a count of independent experiments.
Provenance
Source examples
abacavir · bioavailability · agree
15 documents examined; 83% (Unknown: population and formulation context were not structurally extracted from this source sentence.)
FDA_LABEL:5676d391-f9a4-44be-9604-954b3d8d0e2b (opens source in a new tab)The geometric mean absolute bioavailability of the tablet was 83%.
alemtuzumab · volumeOfDistribution · not_comparable
2 documents examined; 0.18 L/kg (Unknown: population and formulation context were not structurally extracted from this source sentence.); 14.1 L (Unknown: population and formulation context were not structurally extracted from this source sentence.)
FDA_LABEL:4f5f7255-7abc-4328-bd1a-ceaf139ef3e0 (opens source in a new tab)Distribution After the last 30 mg dose, the mean volume of distribution at steady-state was 0.18 L/kg (range 0.1 to 0.4 L/kg).
abiraterone · halfLife · insufficient_context
31 documents examined; 12 ± 5 hours (Unknown: population and formulation context were not structurally extracted from this source sentence.); 18 hours (Unknown: population and formulation context were not structurally extracted from this source sentence.)
FDA_LABEL:c9eb9b46-f847-40a8-802c-a51b40406d5a (opens source in a new tab)Elimination In patients with metastatic CRPC, the mean terminal half-life of abiraterone in plasma (mean ± SD) is 12 ± 5 hours.
Artifact used for this view: data/source-consensus.ndjson. The reader resolves the current run first and uses the checked-in compatibility run only when a current artifact is absent.
Schema
Fields in the public projection
| Field | Type | Meaning |
|---|---|---|
| medicineSlug | string | Stable RNAWiki medicine route key. |
| field | string | Recorded pharmacokinetic field being compared. |
| comparisonState | string | agree (printed-reading agreement), differ (context-matched comparable disjoint values), not_comparable (unit/denominator mismatch), or insufficient_context. Every state remains declared even when its current count is zero. |
| comparisonReasons | string[] | Deterministic codes explaining the state. |
| documentsExamined | number | Recorded source documents considered for the field. |
| sourceCount | number | Recorded source readings represented. |
| agreementRate | number | Share represented by the leading normalized printed-reading group; not a confidence score or clinical agreement probability. |
| readings | consensus-reading[] | Complete, untruncated reading groups. Each keeps the printed display, numeric value when parsed, unit, population context, source count, and every source identity, version/effective date or explicit absence, retrieval date, locator, safe link, and excerpt. |
Reader
Search and filter the rows
Showing 851–860 of 1,681 matching rows. Filters and search terms remain attached when you move between pages or open the API view.
Projected row 851
- Medicine slug
- levonorgestrel
- Compared field
- halfLife
- Comparison state
- insufficient_context
- Reason codes
- STRUCTURED_CONTEXT_MISSING
- Documents examined
- 55
- Source count
- 4
- Agreement rate
- 0.75
- Recorded readings
20 hours
- Numeric value
- 20
- Unit
- hours
- Source records
- 3
Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.
Show all 3 source records
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:dcbd6aa2-b3fa-479a-a676-56ea742962fc (opens source in a new tab)
Levonorgestrel label
Version not recorded · Effective date not recorded
Elimination Following intravenous administration of 0.09 mg LNG to healthy volunteers, the total clearance of LNG is approximately 1 mL/min/kg and the elimination half-life is approximately 20 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:2e07c155-21e1-4781-9633-ce8bddd47080 (opens source in a new tab)
Levonorgestrel label
Version not recorded · Effective date not recorded
Elimination Following intravenous administration of 0.09 mg LNG to healthy volunteers, the total clearance of LNG is approximately 1 mL/min/kg and the elimination half-life is approximately 20 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:9f44ff35-e052-49cd-a1c2-0bfd87d49309 (opens source in a new tab)
Levonorgestrel label
Version not recorded · Effective date not recorded
Elimination Following intravenous administration of 0.09 mg LNG to healthy volunteers, the total clearance of LNG is approximately 1 mL/min/kg and the elimination half-life is approximately 20 hours.
13.9 ± 3.2 hours
- Numeric value
- 13.9
- Unit
- hours
- Source records
- 1
Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.
Show all 1 source records
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:aaf0eb2a-f88a-4f26-a445-0fd30176c326 (opens source in a new tab)
Levonorgestrel label
Version not recorded · Effective date not recorded
Elimination The elimination half-life of LNG after a single oral administration is approximately 13.9 ± 3.2 hours.
Projected row 852
- Medicine slug
- levonorgestrel
- Compared field
- volumeOfDistribution
- Comparison state
- agree
- Reason codes
- COMPATIBLE_VALUES_OVERLAP
- Documents examined
- 55
- Source count
- 3
- Agreement rate
- 1
- Recorded readings
1.8 L/kg
- Numeric value
- 1.8
- Unit
- L/kg
- Source records
- 3
Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.
Show all 3 source records
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:dcbd6aa2-b3fa-479a-a676-56ea742962fc (opens source in a new tab)
Levonorgestrel label
Version not recorded · Effective date not recorded
The apparent volume of distribution of LNG is reported to be approximately 1.8 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:2e07c155-21e1-4781-9633-ce8bddd47080 (opens source in a new tab)
Levonorgestrel label
Version not recorded · Effective date not recorded
Distribution The apparent volume of distribution of LNG is reported to be approximately 1.8 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:9f44ff35-e052-49cd-a1c2-0bfd87d49309 (opens source in a new tab)
Levonorgestrel label
Version not recorded · Effective date not recorded
Distribution The apparent volume of distribution of LNG is reported to be approximately 1.8 L/kg.
Projected row 853
- Medicine slug
- levorphanol
- Compared field
- halfLife
- Comparison state
- agree
- Reason codes
- COMPATIBLE_VALUES_OVERLAP
- Documents examined
- 8
- Source count
- 8
- Agreement rate
- 1
- Recorded readings
11 to 16 hours
- Numeric value
- 11
- Unit
- hours
- Source records
- 8
Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.
Show all 8 source records
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:6e7ca993-c8b9-4510-a2b0-5bcc678d2571 (opens source in a new tab)
Levorphanol label
Version not recorded · Effective date not recorded
Following IV administration plasma concentrations of levorphanol decline in a triexponential manner with a terminal half-life of 11 to 16 hours and a clearance of 0.78 to 1.1 L/kg/hr.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:113a713f-830b-481c-bfa6-d44e3ac27f80 (opens source in a new tab)
Levorphanol label
Version not recorded · Effective date not recorded
Following IV administration plasma concentrations of levorphanol decline in a triexponential manner with a terminal half-life of 11 to 16 hours and a clearance of 0.78 to 1.1 L/kg/hr.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:759c7040-0be0-4d17-be97-e467e423eaa8 (opens source in a new tab)
Levorphanol label
Version not recorded · Effective date not recorded
Following IV administration plasma concentrations of levorphanol decline in a triexponential manner with a terminal half-life of 11 to 16 hours and a clearance of 0.78 to 1.1 L/kg/hr.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:438cf3ea-04fe-4626-9f0f-adcda7633651 (opens source in a new tab)
Levorphanol label
Version not recorded · Effective date not recorded
Following IV administration plasma concentrations of levorphanol decline in a triexponential manner with a terminal half-life of 11 to 16 hours and a clearance of 0.78 to 1.1 L/kg/hr.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:deed8652-9b9d-48b4-8c3e-9fdd7c46237e (opens source in a new tab)
Levorphanol label
Version not recorded · Effective date not recorded
Following IV administration plasma concentrations of levorphanol decline in a triexponential manner with a terminal half-life of 11 to16 hours and a clearance of 0.78 to 1.1 L/kg/hr.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:a50debe1-90b3-4931-9ec0-67e88dd21b04 (opens source in a new tab)
Levorphanol label
Version not recorded · Effective date not recorded
Following IV administration plasma concentrations of levorphanol decline in a triexponential manner with a terminal half-life of 11 to 16 hours and a clearance of 0.78 to 1.1 L/kg/hr.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:b2ab70e4-ca0c-4a73-9c98-974bf94e890c (opens source in a new tab)
Levorphanol label
Version not recorded · Effective date not recorded
Following IV administration plasma concentrations of levorphanol decline in a triexponential manner with a terminal half-life of 11 to16 hours and a clearance of 0.78 to 1.1 L/kg/hr.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:d7587868-561c-4e04-b02c-36a4b653a762 (opens source in a new tab)
Levorphanol label
Version not recorded · Effective date not recorded
Following IV administration plasma concentrations of levorphanol decline in a triexponential manner with a terminal half-life of 11 to 16 hours and a clearance of 0.78 to 1.1 L/kg/hr.
Projected row 854
- Medicine slug
- levorphanol
- Compared field
- proteinBinding
- Comparison state
- agree
- Reason codes
- COMPATIBLE_VALUES_OVERLAP
- Documents examined
- 8
- Source count
- 8
- Agreement rate
- 1
- Recorded readings
40%
- Numeric value
- 40
- Unit
- %
- Source records
- 8
Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.
Show all 8 source records
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:6e7ca993-c8b9-4510-a2b0-5bcc678d2571 (opens source in a new tab)
Levorphanol label
Version not recorded · Effective date not recorded
In vitro studies of protein binding indicate that levorphanol is only 40% bound to plasma proteins.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:113a713f-830b-481c-bfa6-d44e3ac27f80 (opens source in a new tab)
Levorphanol label
Version not recorded · Effective date not recorded
In vitro studies of protein binding indicate that levorphanol is only 40% bound to plasma proteins.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:759c7040-0be0-4d17-be97-e467e423eaa8 (opens source in a new tab)
Levorphanol label
Version not recorded · Effective date not recorded
In vitro studies of protein binding indicate that levorphanol is only 40% bound to plasma proteins.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:438cf3ea-04fe-4626-9f0f-adcda7633651 (opens source in a new tab)
Levorphanol label
Version not recorded · Effective date not recorded
In vitro studies of protein binding indicate that levorphanol is only 40% bound to plasma proteins.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:deed8652-9b9d-48b4-8c3e-9fdd7c46237e (opens source in a new tab)
Levorphanol label
Version not recorded · Effective date not recorded
In vitro studies of protein binding indicate that levorphanol is only 40% bound to plasma proteins.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:a50debe1-90b3-4931-9ec0-67e88dd21b04 (opens source in a new tab)
Levorphanol label
Version not recorded · Effective date not recorded
In vitro studies of protein binding indicate that levorphanol is only 40% bound to plasma proteins.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:b2ab70e4-ca0c-4a73-9c98-974bf94e890c (opens source in a new tab)
Levorphanol label
Version not recorded · Effective date not recorded
In vitro studies of protein binding indicate that levorphanol is only 40% bound to plasma proteins.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:d7587868-561c-4e04-b02c-36a4b653a762 (opens source in a new tab)
Levorphanol label
Version not recorded · Effective date not recorded
In vitro studies of protein binding indicate that levorphanol is only 40% bound to plasma proteins.
Projected row 855
- Medicine slug
- levorphanol
- Compared field
- tMax
- Comparison state
- agree
- Reason codes
- COMPATIBLE_VALUES_OVERLAP
- Documents examined
- 8
- Source count
- 8
- Agreement rate
- 1
- Recorded readings
1 hour
- Numeric value
- 1
- Unit
- hours
- Source records
- 8
Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.
Show all 8 source records
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:6e7ca993-c8b9-4510-a2b0-5bcc678d2571 (opens source in a new tab)
Levorphanol label
Version not recorded · Effective date not recorded
Levorphanol is well absorbed after PO administration with peak plasma concentrations occurring approximately 1 hour after dosing.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:113a713f-830b-481c-bfa6-d44e3ac27f80 (opens source in a new tab)
Levorphanol label
Version not recorded · Effective date not recorded
Levorphanol is well absorbed after PO administration with peak plasma concentrations occurring approximately 1 hour after dosing.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:759c7040-0be0-4d17-be97-e467e423eaa8 (opens source in a new tab)
Levorphanol label
Version not recorded · Effective date not recorded
Levorphanol is well absorbed after PO administration with peak plasma concentrations occurring approximately 1 hour after dosing.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:438cf3ea-04fe-4626-9f0f-adcda7633651 (opens source in a new tab)
Levorphanol label
Version not recorded · Effective date not recorded
Levorphanol is well absorbed after PO administration with peak plasma concentrations occurring approximately 1 hour after dosing.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:deed8652-9b9d-48b4-8c3e-9fdd7c46237e (opens source in a new tab)
Levorphanol label
Version not recorded · Effective date not recorded
Levorphanol is well absorbed after PO administration with peak plasma concentrations occurring approximately 1 hour after dosing.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:a50debe1-90b3-4931-9ec0-67e88dd21b04 (opens source in a new tab)
Levorphanol label
Version not recorded · Effective date not recorded
Levorphanol is well absorbed after PO administration with peak plasma concentrations occurring approximately 1 hour after dosing.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:b2ab70e4-ca0c-4a73-9c98-974bf94e890c (opens source in a new tab)
Levorphanol label
Version not recorded · Effective date not recorded
Levorphanol is well absorbed after PO administration with peak plasma concentrations occurring approximately 1 hour after dosing.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:d7587868-561c-4e04-b02c-36a4b653a762 (opens source in a new tab)
Levorphanol label
Version not recorded · Effective date not recorded
Levorphanol is well absorbed after PO administration with peak plasma concentrations occurring approximately 1 hour after dosing.
Projected row 856
- Medicine slug
- levorphanol
- Compared field
- volumeOfDistribution
- Comparison state
- agree
- Reason codes
- COMPATIBLE_VALUES_OVERLAP
- Documents examined
- 8
- Source count
- 8
- Agreement rate
- 1
- Recorded readings
10 to 13 L/kg
- Numeric value
- 10
- Unit
- L/kg
- Source records
- 8
Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.
Show all 8 source records
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:6e7ca993-c8b9-4510-a2b0-5bcc678d2571 (opens source in a new tab)
Levorphanol label
Version not recorded · Effective date not recorded
Levorphanol is rapidly distributed (<1 hr) and redistributed (1 to 2 hours) following IV administration and has a steady-state volume of distribution of 10 to 13 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:113a713f-830b-481c-bfa6-d44e3ac27f80 (opens source in a new tab)
Levorphanol label
Version not recorded · Effective date not recorded
Levorphanol is rapidly distributed (<1 hr) and redistributed (1 to 2 hours) following IV administration and has a steady-state volume of distribution of 10 to 13 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:759c7040-0be0-4d17-be97-e467e423eaa8 (opens source in a new tab)
Levorphanol label
Version not recorded · Effective date not recorded
Levorphanol is rapidly distributed (<1 hr) and redistributed (1 to 2 hours) following IV administration and has a steady-state volume of distribution of 10 to 13 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:438cf3ea-04fe-4626-9f0f-adcda7633651 (opens source in a new tab)
Levorphanol label
Version not recorded · Effective date not recorded
Levorphanol is rapidly distributed (<1 hr) and redistributed (1 to 2 hours) following IV administration and has a steady-state volume of distribution of 10 to 13 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:deed8652-9b9d-48b4-8c3e-9fdd7c46237e (opens source in a new tab)
Levorphanol label
Version not recorded · Effective date not recorded
Levorphanol is rapidly distributed (<1 hr) and redistributed (1 to 2 hours) following IV administration and has a steady-state volume of distribution of 10 to 13 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:a50debe1-90b3-4931-9ec0-67e88dd21b04 (opens source in a new tab)
Levorphanol label
Version not recorded · Effective date not recorded
Levorphanol is rapidly distributed (<1 hr) and redistributed (1 to 2 hours) following IV administration and has a steady-state volume of distribution of 10 to 13 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:b2ab70e4-ca0c-4a73-9c98-974bf94e890c (opens source in a new tab)
Levorphanol label
Version not recorded · Effective date not recorded
Levorphanol is rapidly distributed (<1 hr) and redistributed (1 to 2 hours) following IV administration and has a steady-state volume of distribution of 10 to 13 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:d7587868-561c-4e04-b02c-36a4b653a762 (opens source in a new tab)
Levorphanol label
Version not recorded · Effective date not recorded
Levorphanol is rapidly distributed (<1 hr) and redistributed (1 to 2 hours) following IV administration and has a steady-state volume of distribution of 10 to 13 L/kg.
Projected row 857
- Medicine slug
- levothyroxine
- Compared field
- proteinBinding
- Comparison state
- agree
- Reason codes
- COMPATIBLE_VALUES_OVERLAP
- Documents examined
- 287
- Source count
- 5
- Agreement rate
- 1
- Recorded readings
20%
- Numeric value
- 20
- Unit
- %
- Source records
- 5
Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.
Show all 5 source records
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:152d071f-d4aa-46d2-b397-61c1cabdd86d (opens source in a new tab)
Levothyroxine label
Version not recorded · Effective date not recorded
Drug or Drug Class Carbamazepine Hydantoins Phenytoin and carbamazepine reduce serum protein binding of levothyroxine, and total- and free-T 4 may be reduced by 20% to 40%, but most patients have normal serum TSH levels and are clinically euthyroid.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:3361138a-6e6f-e8df-e063-6294a90af2de (opens source in a new tab)
Levothyroxine label
Version not recorded · Effective date not recorded
Drug or Drug Class Carbamazepine Hydantoins Phenytoin and carbamazepine reduce serum protein binding of levothyroxine, and total- and free-T 4 may be reduced by 20% to 40%, but most patients have normal serum TSH levels and are clinically euthyroid.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:76139990-1355-cfb6-e053-2991aa0ace5b (opens source in a new tab)
Levothyroxine label
Version not recorded · Effective date not recorded
Drug or Drug Class Carbamazepine Hydantoins Phenytoin and carbamazepine reduce serum protein binding of levothyroxine, and total- and free-T 4 may be reduced by 20% to 40%, but most patients have normal serum TSH levels and are clinically euthyroid.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:bf8a952c-f05b-4814-b55a-ed04be015269 (opens source in a new tab)
Levothyroxine label
Version not recorded · Effective date not recorded
Drug or Drug Class Carbamazepine Hydantoins Phenytoin and carbamazepine reduce serum protein binding of levothyroxine and total- and free-T 4 may be reduced by 20% to 40%, but most patients have normal serum TSH levels and are clinically euthyroid.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:ae9954a5-e196-449c-abea-ebe4afbee517 (opens source in a new tab)
Levothyroxine label
Version not recorded · Effective date not recorded
Drug or Drug Class Carbamazepine Hydantoins Phenytoin and carbamazepine reduce serum protein binding of levothyroxine, and total-and free- T 4 may be reduced by 20% to 40%, but most patients have normal serum TSH levels and are clinically euthyroid.
Projected row 858
- Medicine slug
- lidocaine
- Compared field
- halfLife
- Comparison state
- insufficient_context
- Reason codes
- STRUCTURED_CONTEXT_MISSING
- Documents examined
- 867
- Source count
- 117
- Agreement rate
- 0.615385
- Recorded readings
1.5 to 2 hours
- Numeric value
- 1.5
- Unit
- hours
- Source records
- 72
Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.
Show all 72 source records
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:9920daef-b156-4a14-b641-f714191ffb5c (opens source in a new tab)
Lidocaine label
Version not recorded · Effective date not recorded
Studies of lidocaine HCl metabolism following intravenous bolus injections have shown that the elimination half-life of this agent is typically 1.5 to 2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:6702589d-6a15-40fe-877a-a9a1a4ad0f7a (opens source in a new tab)
Lidocaine label
Version not recorded · Effective date not recorded
Studies of lidocaine metabolism following intravenous bolus injections have shown that the elimination half-life of this agent is typically 1.5 to 2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:1c4c9ce5-f12d-9c47-e063-6294a90a0b3c (opens source in a new tab)
Lidocaine label
Version not recorded · Effective date not recorded
Studies of lidocaine metabolism following intravenous bolus injections have shown that the elimination half-life of this agent is typically 1.5 to 2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:499b4443-7aed-4ac5-ab16-f47e759c3201 (opens source in a new tab)
Lidocaine label
Version not recorded · Effective date not recorded
Studies of lidocaine metabolism following intravenous bolus injections have shown that the elimination half-life of this agent is typically 1.5 to 2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:eaa15be7-11ea-49bc-ac07-739075453be6 (opens source in a new tab)
Lidocaine label
Version not recorded · Effective date not recorded
Studies of lidocaine metabolism following intravenous bolus injections have shown that the elimination half-life of this agent is typically 1.5 to 2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:b7a77ad1-821b-4388-a97c-aadb1340c536 (opens source in a new tab)
Lidocaine label
Version not recorded · Effective date not recorded
Studies of lidocaine metabolism following intravenous bolus injections have shown that the elimination half-life of this agent is typically 1.5 to 2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:58c9afe4-dc36-4f71-8e76-8dff63dc35fb (opens source in a new tab)
Lidocaine label
Version not recorded · Effective date not recorded
Studies of lidocaine metabolism following intravenous bolus injections have shown that the elimination half-life of this agent is typically 1.5 to 2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:c5d27da0-e495-4bb6-a7e1-8eaa6595eb71 (opens source in a new tab)
Lidocaine label
Version not recorded · Effective date not recorded
Studies of lidocaine metabolism following intravenous bolus injections have shown that the elimination half-life of this agent is typically 1.5 to 2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:7bb5c092-91da-4789-b348-58548703d716 (opens source in a new tab)
Lidocaine label
Version not recorded · Effective date not recorded
Studies of lidocaine metabolism following intravenous bolus injections have shown that the elimination half-life of this agent is typically 1.5 to 2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:967b0c5d-679d-4b69-9d6a-bc322baf6e04 (opens source in a new tab)
Lidocaine label
Version not recorded · Effective date not recorded
Studies of lidocaine metabolism following intravenous bolus injections have shown that the elimination half-life of this agent is typically 1.5 to 2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:b8663046-67a4-4858-e053-2a95a90a8aed (opens source in a new tab)
Lidocaine label
Version not recorded · Effective date not recorded
Studies of lidocaine metabolism following intravenous bolus injections have shown that the elimination half-life of this agent is typically 1.5 to 2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:5eb2c62f-5352-41d7-bd66-c65b1988a9ab (opens source in a new tab)
Lidocaine label
Version not recorded · Effective date not recorded
Studies of lidocaine metabolism following intravenous bolus injections have shown that the elimination half-life of this agent is typically 1.5 to 2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:850bdb6a-85d9-441d-8666-7a61311386b6 (opens source in a new tab)
Lidocaine label
Version not recorded · Effective date not recorded
Studies of lidocaine metabolism following intravenous bolus injections have shown that the elimination half-life of this agent is typically 1.5 to 2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:aa1c9d39-1283-8c6b-e053-2a95a90af5b5 (opens source in a new tab)
Lidocaine label
Version not recorded · Effective date not recorded
Studies of lidocaine metabolism following intravenous bolus injections have shown that the elimination half-life of this agent is typically 1.5 to 2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:3ff29d56-8f20-6376-e063-6294a90a667b (opens source in a new tab)
Lidocaine label
Version not recorded · Effective date not recorded
Studies of lidocaine metabolism following intravenous bolus injections have shown that the elimination half-life of this agent is typically 1.5 to 2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:c58257bf-f06b-48d1-92df-a680dbd5eea0 (opens source in a new tab)
Lidocaine label
Version not recorded · Effective date not recorded
Studies of lidocaine metabolism following intravenous bolus injections have shown that the elimination half-life of this agent is typically 1.5 to 2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:2bb5b298-3802-446c-b8cd-313e84bff04e (opens source in a new tab)
Lidocaine label
Version not recorded · Effective date not recorded
Studies of lidocaine metabolism following intravenous bolus injections have shown that the elimination half-life of this agent is typically 1.5 to 2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f73d4546-c9ac-4155-8492-552d6ce70c84 (opens source in a new tab)
Lidocaine label
Version not recorded · Effective date not recorded
Studies of lidocaine metabolism following intravenous bolus injections have shown that the elimination half-life of this agent is typically 1.5 to 2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f18b8413-8f52-a927-e053-2a95a90a402a (opens source in a new tab)
Lidocaine label
Version not recorded · Effective date not recorded
Studies of lidocaine metabolism following intravenous bolus injections have shown that the elimination half-life of this agent is typically 1.5 to 2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:6fe7721d-42b3-4284-936b-a448ca530c45 (opens source in a new tab)
Lidocaine label
Version not recorded · Effective date not recorded
Studies of lidocaine metabolism following intravenous bolus injections have shown that the elimination half-life of this agent is typically 1.5 to 2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:c7a7bf74-d67e-cc5a-e053-2a95a90a2957 (opens source in a new tab)
Lidocaine label
Version not recorded · Effective date not recorded
Studies of Lidocaine metabolism following intravenous bolus injections have shown that the elimination half-life of this agent is typically 1.5 to 2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:ffb2d794-2c88-48a2-beff-d01b6fcea51f (opens source in a new tab)
Lidocaine label
Version not recorded · Effective date not recorded
Studies of lidocaine metabolism following intravenous bolus injections have shown that the elimination half-life of this agent is typically 1.5 to 2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:d1509740-f9f1-44e3-8fde-51d8683fcd87 (opens source in a new tab)
Lidocaine label
Version not recorded · Effective date not recorded
Studies of lidocaine metabolism following intravenous bolus injections have shown that the elimination half-life of this agent is typically 1.5 to 2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:259f7b21-98c7-3b41-e063-6294a90a34fa (opens source in a new tab)
Lidocaine label
Version not recorded · Effective date not recorded
Studies of lidocaine metabolism following intravenous bolus injections have shown that the elimination half-life of this agent is typically 1.5 to 2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:ae758020-a508-4a2e-8164-e6c324e826a3 (opens source in a new tab)
Lidocaine label
Version not recorded · Effective date not recorded
Studies of lidocaine metabolism following intravenous bolus injections have shown that the elimination half-life of this agent is typically 1.5 to 2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:b948d6fe-3893-39a1-e053-2995a90ae64c (opens source in a new tab)
Lidocaine label
Version not recorded · Effective date not recorded
Studies of lidocaine metabolism following intravenous bolus injections have shown that the elimination half-life of this agent is typically 1.5 to 2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:e1badbba-59af-e451-e053-2a95a90a49f8 (opens source in a new tab)
Lidocaine label
Version not recorded · Effective date not recorded
Studies of lidocaine metabolism following intravenous bolus injections have shown that the elimination half-life of this agent is typically 1.5 to 2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:4134f30d-5cb0-e14b-e063-6394a90a4523 (opens source in a new tab)
Lidocaine label
Version not recorded · Effective date not recorded
Studies of lidocaine metabolism following intravenous bolus injections have shown that the elimination half-life of this agent is typically 1.5 to 2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:54df7353-5411-43ad-bd7b-a3d4d62c72c6 (opens source in a new tab)
Lidocaine label
Version not recorded · Effective date not recorded
Studies of lidocaine metabolism following intravenous bolus injections have shown that the elimination half-life of this agent is typically 1.5 to 2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:4806f94d-cbac-4107-b93b-8f715868ffb3 (opens source in a new tab)
Lidocaine label
Version not recorded · Effective date not recorded
Studies of lidocaine metabolism following intravenous bolus injections have shown that the elimination half-life of this agent is typically 1.5 to 2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:0f3ea647-a593-017b-e063-6294a90a38ca (opens source in a new tab)
Lidocaine label
Version not recorded · Effective date not recorded
Studies of Lidocaine metabolism following intravenous bolus injections have shown that the elimination half-life of this agent is typically 1.5 to 2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:c4c0df51-cc37-323d-e053-2995a90a154a (opens source in a new tab)
Lidocaine label
Version not recorded · Effective date not recorded
Studies of lidocaine metabolism following intravenous bolus injections have shown that the elimination half-life of this agent is typically 1.5 to 2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:c4bf5905-add7-1cb0-e053-2995a90a7334 (opens source in a new tab)
Lidocaine label
Version not recorded · Effective date not recorded
Studies of lidocaine metabolism following intravenous bolus injections have shown that the elimination half-life of this agent is typically 1.5 to 2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:1e183af7-73d7-ff32-e063-6294a90a305b (opens source in a new tab)
Lidocaine label
Version not recorded · Effective date not recorded
Studies of lidocaine metabolism following intravenous bolus injections have shown that the elimination half-life of this agent is typically 1.5 to 2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f18bae4a-11ac-7319-e053-2995a90ad1e8 (opens source in a new tab)
Lidocaine label
Version not recorded · Effective date not recorded
Studies of lidocaine metabolism following intravenous bolus injections have shown that the elimination half-life of this agent is typically 1.5 to 2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:17880468-873f-6465-e063-6294a90a9c73 (opens source in a new tab)
Lidocaine label
Version not recorded · Effective date not recorded
Studies of lidocaine metabolism following intravenous bolus injections have shown that the elimination half-life of this agent is typically 1.5 to 2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:851844f5-912d-4598-84f3-c0277968b5f1 (opens source in a new tab)
Lidocaine label
Version not recorded · Effective date not recorded
Studies of lidocaine metabolism following intravenous bolus injections have shown that the elimination half-life of this agent is typically 1.5 to 2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:65760723-75cd-472c-96e1-7d05f95b4686 (opens source in a new tab)
Lidocaine label
Version not recorded · Effective date not recorded
Studies of lidocaine metabolism following intravenous bolus injections have shown that the elimination half-life of this agent is typically 1.5 to 2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:2e0f4ca3-874a-f0d0-e063-6294a90a0b65 (opens source in a new tab)
Lidocaine label
Version not recorded · Effective date not recorded
Studies of lidocaine metabolism following intravenous bolus injections have shown that the elimination half-life of this agent is typically 1.5 to 2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:23efec58-67cc-418d-85f5-7ef156443cbf (opens source in a new tab)
Lidocaine label
Version not recorded · Effective date not recorded
Studies of lidocaine metabolism following intravenous bolus injections have shown that the elimination half-life of this agent is typically 1.5 to 2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:1c0abe84-5404-404e-b882-e910e4d43ffb (opens source in a new tab)
Lidocaine label
Version not recorded · Effective date not recorded
Studies of lidocaine metabolism following intravenous bolus injections have shown that the elimination half-life of this agent is typically 1.5 to 2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:3a9a6630-e470-b794-e063-6394a90aaab5 (opens source in a new tab)
Lidocaine label
Version not recorded · Effective date not recorded
Studies of lidocaine metabolism following intravenous bolus injections have shown that the elimination half-life of this agent is typically 1.5 to 2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:00725e5b-694c-b9e1-e063-6294a90a4182 (opens source in a new tab)
Lidocaine label
Version not recorded · Effective date not recorded
Studies of lidocaine metabolism following intravenous bolus injections have shown that the elimination half-life of this agent is typically 1.5 to 2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:70ff9fb7-d323-4fe6-b1b1-6033e05f0749 (opens source in a new tab)
Lidocaine label
Version not recorded · Effective date not recorded
Studies of lidocaine metabolism following intravenous bolus injections have shown that the elimination half-life of this agent is typically 1.5 to 2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:cde68b0c-a1ee-421d-9ca8-bc571d2990ab (opens source in a new tab)
Lidocaine label
Version not recorded · Effective date not recorded
Studies of lidocaine metabolism following intravenous bolus injections have shown that the elimination half-life of this agent is typically 1.5 to 2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:2c48cfac-81eb-4a81-8590-bc94574dd4c3 (opens source in a new tab)
Lidocaine label
Version not recorded · Effective date not recorded
Studies of lidocaine metabolism following intravenous bolus injections have shown that the elimination half-life of this agent is typically 1.5 to 2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:cf715e54-c413-1e8f-e053-2995a90a076d (opens source in a new tab)
Lidocaine label
Version not recorded · Effective date not recorded
Studies of lidocaine metabolism following intravenous bolus injections have shown that the elimination half-life of this agent is typically 1.5 to 2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:cc9eeba3-695d-d14e-e053-2a95a90a5c03 (opens source in a new tab)
Lidocaine label
Version not recorded · Effective date not recorded
Studies of Lidocaine metabolism following intravenous bolus injections have shown that the elimination half-life of this agent is typically 1.5 to 2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:0cbc37d3-c2d6-4747-9834-7c23b38fcc20 (opens source in a new tab)
Lidocaine label
Version not recorded · Effective date not recorded
Studies of lidocaine metabolism following intravenous bolus injections have shown that the elimination half-life of this agent is typically 1.5 to 2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:b45a7d2f-111f-4390-9b90-570b1c9f5ffc (opens source in a new tab)
Lidocaine label
Version not recorded · Effective date not recorded
Studies of lidocaine metabolism following intravenous bolus injections have shown that the elimination half-life of this agent is typically 1.5 to 2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:960f6d0a-82af-45e9-89d5-cea808004ebb (opens source in a new tab)
Lidocaine label
Version not recorded · Effective date not recorded
Studies of lidocaine metabolism following intravenous bolus injections have shown that the elimination half-life of this agent is typically 1.5 to 2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f9b290d2-0e24-4ca8-bca2-3016f5c404df (opens source in a new tab)
Lidocaine label
Version not recorded · Effective date not recorded
Studies of lidocaine metabolism following intravenous bolus injections have shown that the elimination half-life of this agent is typically 1.5 to 2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:8a85ea77-91ad-4222-9bfe-2ffaf73182e8 (opens source in a new tab)
Lidocaine label
Version not recorded · Effective date not recorded
Studies of lidocaine metabolism following intravenous bolus injections have shown that the elimination half-life of this agent is typically 1.5 to 2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:c4c16714-6b1f-857e-e053-2a95a90a74e4 (opens source in a new tab)
Lidocaine label
Version not recorded · Effective date not recorded
Studies of lidocaine metabolism following intravenous bolus injections have shown that the elimination half-life of this agent is typically 1.5 to 2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:ed43f2c3-606c-4998-8fca-ee9b13cd18db (opens source in a new tab)
Lidocaine label
Version not recorded · Effective date not recorded
Studies of lidocaine HCl metabolism following intravenous bolus injections have shown that the elimination half-life of this agent is typically 1.5 to 2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:845b96c1-36a3-431f-8316-112ae881d934 (opens source in a new tab)
Lidocaine label
Version not recorded · Effective date not recorded
Studies of lidocaine hydrochloride metabolism following intravenous bolus injections have shown that the elimination half-life of this agent is typically 1.5 to 2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f0617ab8-555f-4cbe-9795-c922f5ef176e (opens source in a new tab)
Lidocaine label
Version not recorded · Effective date not recorded
Studies of lidocaine metabolism following intravenous bolus injections have shown that the elimination half-life of this agent is typically 1.5 to 2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:5b4b36dd-da60-47de-a2c1-517a52ab3549 (opens source in a new tab)
Lidocaine label
Version not recorded · Effective date not recorded
Studies of lidocaine metabolism following intravenous bolus injections have shown that the elimination half-life of this agent is typically 1.5 to 2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:185d3e09-4005-b032-e063-6294a90a5efe (opens source in a new tab)
Lidocaine label
Version not recorded · Effective date not recorded
Studies of lidocaine metabolism following intravenous bolus injections have shown that the elimination half-life of this agent is typically 1.5 to 2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:1e8239f6-8d53-4b04-8bf8-c2cefe3ab5c3 (opens source in a new tab)
Lidocaine label
Version not recorded · Effective date not recorded
Studies of lidocaine metabolism following intravenous bolus injections have shown that the elimination half-life of this agent is typically 1.5 to 2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:3a602aee-09e2-892c-e063-6294a90a558f (opens source in a new tab)
Lidocaine label
Version not recorded · Effective date not recorded
Studies of lidocaine metabolism following intravenous bolus injections have shown that the elimination half-life of this agent is typically 1.5 to 2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:c3353e08-2a8c-4ace-ba89-114f7131b8de (opens source in a new tab)
Lidocaine label
Version not recorded · Effective date not recorded
Studies of lidocaine HCl metabolism following intravenous bolus injections have shown that the elimination half-life of this agent is typically 1.5 to 2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f581248d-697d-4174-aa42-afdf4ecce02e (opens source in a new tab)
Lidocaine label
Version not recorded · Effective date not recorded
Studies of lidocaine HCl metabolism following intravenous bolus injections have shown that the elimination half-life of this agent is typically 1.5 to 2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:09c10cd0-b634-ab9d-e063-6294a90aa544 (opens source in a new tab)
Lidocaine label
Version not recorded · Effective date not recorded
Studies of lidocaine metabolism following intravenous bolus injections have shown that the elimination half-life of this agent is typically 1.5 to 2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:6abf3773-0e60-48b1-9d5c-adc590363d13 (opens source in a new tab)
Lidocaine label
Version not recorded · Effective date not recorded
Studies of lidocaine metabolism following intravenous bolus injections have shown that the elimination half-life of this agent is typically 1.5 to 2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:1a156ffe-1ec9-d2f9-e063-6394a90a3381 (opens source in a new tab)
Lidocaine label
Version not recorded · Effective date not recorded
Studies of lidocaine metabolism following intravenous bolus injections have shown that the elimination half-life of this agent is typically 1.5 to 2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f1007717-528a-42e2-94aa-db0edf3bb603 (opens source in a new tab)
Lidocaine label
Version not recorded · Effective date not recorded
Studies of lidocaine metabolism following intravenous bolus injections have shown that the elimination half-life of this agent is typically 1.5 to 2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:903cd7bd-6c3d-4068-bb24-e91b1ca1393d (opens source in a new tab)
Lidocaine label
Version not recorded · Effective date not recorded
Studies of lidocaine HCl metabolism following intravenous bolus injections have shown that the elimination half-life of this agent is typically 1.5 to 2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f93cbde5-329a-f880-e053-6294a90a1af2 (opens source in a new tab)
Lidocaine label
Version not recorded · Effective date not recorded
Studies of lidocaine metabolism following intravenous bolus injections have shown that the elimination half-life of this agent is typically 1.5 to 2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:ddaee8bc-f55c-48b1-9b0e-ad1e2dd15a2c (opens source in a new tab)
Lidocaine label
Version not recorded · Effective date not recorded
Studies of lidocaine metabolism following intravenous bolus injections have shown that the elimination half-life of this agent is typically 1.5 to 2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:40949067-a5a8-db8c-e063-6294a90af0fb (opens source in a new tab)
Lidocaine label
Version not recorded · Effective date not recorded
Studies of lidocaine metabolism following intravenous bolus injections have shown that the elimination half-life of this agent is typically 1.5 to 2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:2cc3d25d-cefd-448d-beec-ac602c2110fd (opens source in a new tab)
Lidocaine label
Version not recorded · Effective date not recorded
Studies of lidocaine metabolism following intravenous bolus injections have shown that the elimination half-life of this agent is typically 1.5 to 2 hours.
1.5 to 2.0 hours
- Numeric value
- 1.5
- Unit
- hours
- Source records
- 34
Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.
Show all 34 source records
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:e0bfe16f-7a3f-48e0-a2e6-2ec68159a888 (opens source in a new tab)
Lidocaine label
Version not recorded · Effective date not recorded
Studies of lidocaine metabolism following intravenous bolus injections have shown that the elimination half-life of this agent is typically 1.5 to 2.0 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:3a63652c-92a1-612b-e063-6294a90a034a (opens source in a new tab)
Lidocaine label
Version not recorded · Effective date not recorded
Studies of lidocaine metabolism following intravenous bolus injections have shown that the elimination half-life of this agent is typically 1.5 to 2.0 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:29199070-6dcb-4086-9a68-49e819965dbd (opens source in a new tab)
Lidocaine label
Version not recorded · Effective date not recorded
Studies of lidocaine metabolism following intravenous bolus injections have shown that the elimination half-life of this agent is typically 1.5 to 2.0 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:68bc320f-2871-45b9-815e-bb26081e8249 (opens source in a new tab)
Lidocaine label
Version not recorded · Effective date not recorded
Studies of lidocaine metabolism following intravenous bolus injections have shown that the elimination half-life of this agent is typically 1.5 to 2.0 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:88ca9cba-0c4a-482f-b502-ceefdb1bfbcd (opens source in a new tab)
Lidocaine label
Version not recorded · Effective date not recorded
Studies of lidocaine metabolism following intravenous bolus injections have shown that the elimination half-life of this agent is typically 1.5 to 2.0 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:2f6e0f3d-ceaf-a853-e063-6394a90a8efb (opens source in a new tab)
Lidocaine label
Version not recorded · Effective date not recorded
Studies of lidocaine metabolism following intravenous bolus injections have shown that the elimination half-life of this agent is typically 1.5 to 2.0 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:e8bc96bc-7876-4906-e053-2a95a90ae6ba (opens source in a new tab)
Lidocaine label
Version not recorded · Effective date not recorded
Studies of lidocaine metabolism following intravenous bolus injections have shown that the elimination half-life of this agent is typically 1.5 to 2.0 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:8b1efeaa-31b1-4f34-960f-7a920ac07355 (opens source in a new tab)
Lidocaine label
Version not recorded · Effective date not recorded
Studies of lidocaine metabolism following intravenous bolus injections have shown that the elimination half-life of this agent is typically 1.5 to 2.0 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:259f3f4b-50d0-066c-e063-6394a90a2a1e (opens source in a new tab)
Lidocaine label
Version not recorded · Effective date not recorded
Studies of lidocaine metabolism following intravenous bolus injections have shown that the elimination half-life of this agent is typically 1.5 to 2.0 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:8f79b023-9bd1-4bd6-8fd0-f9efe88abec0 (opens source in a new tab)
Lidocaine label
Version not recorded · Effective date not recorded
Studies of lidocaine metabolism following intravenous bolus injections have shown that the elimination half-life of this agent is typically 1.5 to 2.0 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:4e679a0d-df82-435f-ad46-c871f3c76dfb (opens source in a new tab)
Lidocaine label
Version not recorded · Effective date not recorded
Studies of lidocaine metabolism following intravenous bolus injections have shown that the elimination half-life of this agent is typically 1.5 to 2.0 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f8789807-cc0c-485c-aa98-1bdc39337deb (opens source in a new tab)
Lidocaine label
Version not recorded · Effective date not recorded
Studies of lidocaine metabolism following intravenous bolus injections have shown that the elimination half-life of this agent is typically 1.5 to 2.0 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:c18f0c2b-cd05-4458-888f-47b4a1106937 (opens source in a new tab)
Lidocaine label
Version not recorded · Effective date not recorded
Studies of lidocaine metabolism following intravenous bolus injections have shown that the elimination half-life of this agent is typically 1.5 to 2.0 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:38f31902-99fd-4a63-853e-b5f93dfc5980 (opens source in a new tab)
Lidocaine label
Version not recorded · Effective date not recorded
Studies of lidocaine metabolism following intravenous bolus injections have shown that the elimination half-life of this agent is typically 1.5 to 2.0 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:9b2d4f69-0c84-4956-b5c0-b4410acf62e0 (opens source in a new tab)
Lidocaine label
Version not recorded · Effective date not recorded
Studies of lidocaine metabolism following intravenous bolus injections have shown that the elimination half-life of this agent is typically 1.5 to 2.0 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:9bf01533-ed83-4440-bdc4-4b45729bfc31 (opens source in a new tab)
Lidocaine label
Version not recorded · Effective date not recorded
Studies of lidocaine metabolism following intravenous bolus injections have shown that the elimination half-life of this agent is typically 1.5 to 2.0 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:2c396307-cf12-41d0-89e6-0f4ec74df55e (opens source in a new tab)
Lidocaine label
Version not recorded · Effective date not recorded
Studies of lidocaine metabolism following intravenous bolus injections have shown that the elimination half-life of this agent is typically 1.5 to 2.0 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:11a8b27a-1e25-46e5-bc23-ae5c894b4da4 (opens source in a new tab)
Lidocaine label
Version not recorded · Effective date not recorded
Studies of lidocaine metabolism following intravenous bolus injections have shown that the elimination half-life of this agent is typically 1.5 to 2.0 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:2b9150ea-a876-4511-8d5b-aa72507ef863 (opens source in a new tab)
Lidocaine label
Version not recorded · Effective date not recorded
Studies of lidocaine metabolism following intravenous bolus injections have shown that the elimination half-life of this agent is typically 1.5 to 2.0 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:e7ed90d7-11c0-4781-a727-1fe3659a2948 (opens source in a new tab)
Lidocaine label
Version not recorded · Effective date not recorded
Studies of lidocaine metabolism following intravenous bolus injections have shown that the elimination half-life of this agent is typically 1.5 to 2.0 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:89a4bd73-89f4-4fd7-2c9f-921e1da8f96b (opens source in a new tab)
Lidocaine label
Version not recorded · Effective date not recorded
Studies of lidocaine metabolism following intravenous bolus injections have shown that the elimination half-life of this agent is typically 1.5 to 2.0 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:cbf01b82-c43f-4bed-a1df-7569f4816c76 (opens source in a new tab)
Lidocaine label
Version not recorded · Effective date not recorded
Studies of lidocaine metabolism following intravenous bolus injections have shown that the elimination half-life of this agent is typically 1.5 to 2.0 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:325ddb61-84f5-075c-e063-6294a90ad5e9 (opens source in a new tab)
Lidocaine label
Version not recorded · Effective date not recorded
Studies of lidocaine metabolism following intravenous bolus injections have shown that the elimination half-life of this agent is typically 1.5 to 2.0 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:31a5a48e-27d7-90f3-e063-6294a90a2d9e (opens source in a new tab)
Lidocaine label
Version not recorded · Effective date not recorded
Studies of lidocaine metabolism following intravenous bolus injections have shown that the elimination half-life of this agent is typically 1.5 to 2.0 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:071b2cfd-07ad-46a3-8808-87080d545fd3 (opens source in a new tab)
Lidocaine label
Version not recorded · Effective date not recorded
Studies of lidocaine metabolism following intravenous bolus injections have shown that the elimination half-life of this agent is typically 1.5 to 2.0 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:fd8a640a-b5ca-f0a7-e053-6394a90ad603 (opens source in a new tab)
Lidocaine label
Version not recorded · Effective date not recorded
Studies of lidocaine metabolism following intravenous bolus injections have shown that the elimination half-life of this agent is typically 1.5 to 2.0 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:c788afd3-4554-40c4-8f26-2c31ab9b9b98 (opens source in a new tab)
Lidocaine label
Version not recorded · Effective date not recorded
Studies of lidocaine metabolism following intravenous bolus injections have shown that the elimination half-life of this agent is typically 1.5 to 2.0 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:c98eeb63-c896-4417-b0ad-66c4a87efeee (opens source in a new tab)
Lidocaine label
Version not recorded · Effective date not recorded
Studies of lidocaine metabolism following intravenous bolus injections have shown that the elimination half-life of this agent is typically 1.5 to 2.0 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:29f211ff-dcba-afb0-e063-6294a90afb9b (opens source in a new tab)
Lidocaine label
Version not recorded · Effective date not recorded
Studies of lidocaine metabolism following intravenous bolus injections have shown that the elimination half-life of this agent is typically 1.5 to 2.0 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:a134c265-4fb6-4c78-b9cc-fae8f1fff1cf (opens source in a new tab)
Lidocaine label
Version not recorded · Effective date not recorded
Studies of lidocaine metabolism following intravenous bolus injections have shown that the elimination half-life of this agent is typically 1.5 to 2.0 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:da9707e2-f830-45e2-a300-1f99cf3dd362 (opens source in a new tab)
Lidocaine label
Version not recorded · Effective date not recorded
Studies of lidocaine metabolism following intravenous bolus injections have shown that the elimination half-life of this agent is typically 1.5 to 2.0 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:feb8692a-9c08-0d5c-e053-6394a90a904b (opens source in a new tab)
Lidocaine label
Version not recorded · Effective date not recorded
Studies of lidocaine metabolism following intravenous bolus injections have shown that the elimination half-life of this agent is typically 1.5 to 2.0 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:015cea25-d323-43dd-a92f-593a8e4a2921 (opens source in a new tab)
Lidocaine label
Version not recorded · Effective date not recorded
Studies of lidocaine metabolism following intravenous bolus injections have shown that the elimination half-life of this agent is typically 1.5 to 2.0 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:dfef4554-aeb4-4bdf-9557-648d3e84af3c (opens source in a new tab)
Lidocaine label
Version not recorded · Effective date not recorded
Studies of lidocaine metabolism following intravenous bolus injections have shown that the elimination half-life of this agent is typically 1.5 to 2.0 hours.
3 hours
- Numeric value
- 3
- Unit
- hours
- Source records
- 11
Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.
Show all 11 source records
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:46404c7b-2ea4-e47b-e063-6294a90a779f (opens source in a new tab)
Lidocaine label
Version not recorded · Effective date not recorded
There are data that indicate that the half-life may be 3 hours or longer following infusions of greater than 24 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:ad1ef0a8-88db-4648-c098-d009eaeb4e5b (opens source in a new tab)
Lidocaine label
Version not recorded · Effective date not recorded
There are data that indicate that the half-life may be 3 hours or longer following infusions of greater than 24 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:313a7e1f-c1a9-4fa5-bb83-7256c271b351 (opens source in a new tab)
Lidocaine label
Version not recorded · Effective date not recorded
There are data that indicate that the half-life may be 3 hours or longer following infusions of greater than 24 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:335dfa50-56f3-4c02-b713-8eef4e28eb45 (opens source in a new tab)
Lidocaine label
Version not recorded · Effective date not recorded
There are data that indicate that the half-life may be 3 hours or longer following infusions of greater than 24 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:3f2c33e5-290e-2f89-e063-6394a90aee69 (opens source in a new tab)
Lidocaine label
Version not recorded · Effective date not recorded
There are data that indicate that the half-life may be 3 hours or longer following infusions of greater than 24 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:4e46cac7-00cd-4a01-ba11-9af4960cfbe9 (opens source in a new tab)
Lidocaine label
Version not recorded · Effective date not recorded
There are data that indicate that the half-life may be 3 hours or longer following infusions of greater than 24 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:38560997-cfe4-2f9b-e063-6394a90a834b (opens source in a new tab)
Lidocaine label
Version not recorded · Effective date not recorded
There are data that indicate that the half-life may be 3 hours or longer following infusions of greater than 24 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:2177b6fe-aa37-6f6b-e063-6294a90af09a (opens source in a new tab)
Lidocaine label
Version not recorded · Effective date not recorded
There are data that indicate that the half-life may be 3 hours or longer following infusions of greater than 24 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:6947af02-f4e0-7f9c-e053-2a91aa0a45cd (opens source in a new tab)
Lidocaine label
Version not recorded · Effective date not recorded
There are data that indicate that the half-life may be 3 hours or longer following infusions of greater than 24 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:9c9655fd-89a9-77c8-e053-2a95a90a0c99 (opens source in a new tab)
Lidocaine label
Version not recorded · Effective date not recorded
There are data that indicate that the half-life may be 3 hours or longer following infusions of greater than 24 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:6bcdbee5-014e-6b4c-e053-2a91aa0aecd2 (opens source in a new tab)
Lidocaine label
Version not recorded · Effective date not recorded
There are data that indicate that the half-life may be 3 hours or longer following infusions of greater than 24 hours.
Projected row 859
- Medicine slug
- lidocaine
- Compared field
- volumeOfDistribution
- Comparison state
- agree
- Reason codes
- COMPATIBLE_VALUES_OVERLAP
- Documents examined
- 867
- Source count
- 40
- Agreement rate
- 1
- Recorded readings
0.7 to 2.7 L/kg
- Numeric value
- 0.7
- Unit
- L/kg
- Source records
- 40
Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.
Show all 40 source records
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:80dadfb5-cbe6-475f-9980-a1b255982753 (opens source in a new tab)
Lidocaine label
Version not recorded · Effective date not recorded
Distribution: When lidocaine is administered intravenously to healthy volunteers, the volume of distribution is 0.7 to 2.7 L/kg (mean 1.5 ± 0.6 SD, n=15).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:a1b17507-4560-490d-a388-74e7fd7eaa5e (opens source in a new tab)
Lidocaine label
Version not recorded · Effective date not recorded
Chemical Structure Distribution When lidocaine is administered intravenously to healthy volunteers, the volume of distribution is 0.7 to 2.7 L/kg (mean 1.5 ± 0.6 SD, n = 15).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:1f46bdfd-3a38-49a3-a505-0192790486d0 (opens source in a new tab)
Lidocaine label
Version not recorded · Effective date not recorded
Distribution When lidocaine is administered intravenously to healthy volunteers, the volume of distribution is 0.7 to 2.7 L/kg (mean 1.5 ± 0.6 SD, n = 15).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:ec6a4720-9821-c0fc-e053-2995a90a05df (opens source in a new tab)
Lidocaine label
Version not recorded · Effective date not recorded
Distribution: When lidocaine is administered intravenously to healthy volunteers, the volume of distribution is 0.7 to 2.7 L/kg (mean 1.5 ± 0.6 SD, n=15).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:4e856dd5-f2fa-4acb-a205-f87baf26b8cc (opens source in a new tab)
Lidocaine label
Version not recorded · Effective date not recorded
Figure 1: Mean lidocaine blood concentrations after three consecutive daily applications of three lidocaine patches simultaneously for 12 hours per day in healthy volunteers (n = 15). image description Distribution: When lidocaine is administered intravenously to healthy volunteers, the volume of distribution is 0.7 to 2.7 L/kg (mean 1.5 ± 0.6 SD, n = 15).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:b4db5684-988f-44c4-a81e-5c04b8b0f6e7 (opens source in a new tab)
Lidocaine label
Version not recorded · Effective date not recorded
Distribution When lidocaine is administered intravenously to healthy volunteers, the volume of distribution is 0.7 to 2.7 L/kg (mean 1.5 ± 0.6 SD, n = 15).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f94d388c-8471-885b-e053-6294a90ab67a (opens source in a new tab)
Lidocaine label
Version not recorded · Effective date not recorded
Distribution When lidocaine is administered intravenously to healthy volunteers, the volume of distribution is 0.7 to 2.7 L/kg (mean 1.5 ± 0.6 SD, n = 15).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f7ada189-7463-4bc7-83e7-f140558ecacf (opens source in a new tab)
Lidocaine label
Version not recorded · Effective date not recorded
Figure 1 Distribution When lidocaine is administered intravenously to healthy volunteers, the volume of distribution is 0.7 to 2.7 L/kg (mean 1.5 ± 0.6 SD, n=15).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:0748b9e3-1247-4eeb-8158-3d641b2ad85d (opens source in a new tab)
Lidocaine label
Version not recorded · Effective date not recorded
Figure 1 Distribution When lidocaine is administered intravenously to healthy volunteers, the volume of distribution is 0.7 to 2.7 L/kg (mean 1.5 ± 0.6 SD, n=15).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:323e0ec2-c2e5-47d1-a39f-69ff5c99e324 (opens source in a new tab)
Lidocaine label
Version not recorded · Effective date not recorded
Figure 1 Distribution When lidocaine is administered intravenously to healthy volunteers, the volume of distribution is 0.7 to 2.7 L/kg (mean 1.5 ± 0.6 SD, n=15).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:1e940ba6-3916-4fc4-8886-481fc9685fc1 (opens source in a new tab)
Lidocaine label
Version not recorded · Effective date not recorded
Figure 1 Distribution When lidocaine is administered intravenously to healthy volunteers, the volume of distribution is 0.7 to 2.7 L/kg (mean 1.5 ± 0.6 SD, n=15).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:57edfcb8-272c-8af4-e063-6294a90ae2e5 (opens source in a new tab)
Lidocaine label
Version not recorded · Effective date not recorded
Distribution When lidocaine is administered intravenously to healthy volunteers, the volume of distribution is 0.7 to 2.7 L/kg (mean 1.5 ± 0.6 SD, n = 15).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:0a4cc4f8-9c5d-d03f-e063-6394a90a1b2e (opens source in a new tab)
Lidocaine label
Version not recorded · Effective date not recorded
Distribution When lidocaine is administered intravenously to healthy volunteers, the volume of distribution is 0.7 to 2.7 L/kg (mean 1.5 ± 0.6 SD, n = 15).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:65cf652c-87f2-43c6-a6f8-e4a83b42ce78 (opens source in a new tab)
Lidocaine label
Version not recorded · Effective date not recorded
Distribution When lidocaine is administered intravenously to healthy volunteers, the volume of distribution is 0.7 to 2.7 L/kg (mean 1.5 ± 0.6 SD, n=15).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:19c585f3-e635-44d4-8eb0-14529eb34dca (opens source in a new tab)
Lidocaine label
Version not recorded · Effective date not recorded
Distribution When lidocaine is administered intravenously to healthy volunteers, the volume of distribution is 0.7 to 2.7 L/kg (mean 1.5 ± 0.6 SD, n = 15).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:1b561cc6-1d36-e259-e063-6294a90aacbd (opens source in a new tab)
Lidocaine label
Version not recorded · Effective date not recorded
Figure 1 Distribution When lidocaine is administered intravenously to healthy volunteers, the volume of distribution is 0.7 to 2.7 L/kg (mean 1.5 ± 0.6 SD, n=15).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:e23a92e6-3445-4ba7-9ad2-86a3eec1717e (opens source in a new tab)
Lidocaine label
Version not recorded · Effective date not recorded
Figure 1 Distribution When lidocaine is administered intravenously to healthy volunteers, the volume of distribution is 0.7 to 2.7 L/kg (mean 1.5 ± 0.6 SD, n=15).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:c18799cd-9e11-4196-9ab1-0a2a84585e56 (opens source in a new tab)
Lidocaine label
Version not recorded · Effective date not recorded
Figure 1 Mean lidocaine blood concentrations after three consecutive daily applications of three lidocaine patches simultaneously for 12 hours per day in healthy volunteers (n = 15). 1 Distribution: When lidocaine is administered intravenously to healthy volunteers, the volume of distribution is 0.7 to 2.7 L/kg (mean 1.5 ± 0.6 SD, n=15).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:17e69028-d2c2-4080-8090-cb0cab570196 (opens source in a new tab)
Lidocaine label
Version not recorded · Effective date not recorded
Distribution When lidocaine is administered intravenously to healthy volunteers, the volume of distribution is 0.7 to 2.7 L/kg (mean 1.5 ± 0.6 SD, n = 15).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:94ab1b99-e203-4a14-b852-42d3b37999c3 (opens source in a new tab)
Lidocaine label
Version not recorded · Effective date not recorded
Figure 1 Distribution When lidocaine is administered intravenously to healthy volunteers, the volume of distribution is 0.7 to 2.7 L/kg (mean 1.5 ± 0.6 SD, n=15).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:4611f0da-a41d-4861-9dd6-f16f1b007d33 (opens source in a new tab)
Lidocaine label
Version not recorded · Effective date not recorded
Figure 1 Distribution When lidocaine is administered intravenously to healthy volunteers, the volume of distribution is 0.7 to 2.7 L/kg (mean 1.5 ± 0.6 SD, n=15).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:ebc05cf9-e82b-4f7d-b5e7-3e62025ce68c (opens source in a new tab)
Lidocaine label
Version not recorded · Effective date not recorded
Distribution When lidocaine is administered intravenously to healthy volunteers, the volume of distribution is 0.7 to 2.7 L/kg (mean 1.5 ± 0.6 SD, n = 15).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:9dc3059c-3a3d-5810-e053-2a95a90ab0ba (opens source in a new tab)
Lidocaine label
Version not recorded · Effective date not recorded
Figure 1 Distribution When lidocaine is administered intravenously to healthy volunteers, the volume of distribution is 0.7 to 2.7 L/kg (mean 1.5 ± 0.6 SD, n=15).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:eb808fdf-0420-45e9-ad17-8380d49d5c21 (opens source in a new tab)
Lidocaine label
Version not recorded · Effective date not recorded
Figure 1 Mean lidocaine blood concentrations after three consecutive daily applications of three lidocaine patches simultaneously for 12 hours per day in healthy volunteers (n = 15). 1 Distribution: When lidocaine is administered intravenously to healthy volunteers, the volume of distribution is 0.7 to 2.7 L/kg (mean 1.5 ± 0.6 SD, n=15).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:3c69e03c-e176-2c23-e063-6394a90aa41f (opens source in a new tab)
Lidocaine label
Version not recorded · Effective date not recorded
Figure 1 Distribution When lidocaine is administered intravenously to healthy volunteers, the volume of distribution is 0.7 to 2.7 L/kg (mean 1.5 ± 0.6 SD, n=15).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:67a6bbbd-ab4b-414a-b85c-b7d8c0cfa9d2 (opens source in a new tab)
Lidocaine label
Version not recorded · Effective date not recorded
Distribution When lidocaine is administered intravenously to healthy volunteers, the volume of distribution is 0.7 to 2.7 L/kg (mean 1.5 ± 0.6 SD, n=15).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:6d7fdc43-e493-449e-9af6-825e584b547a (opens source in a new tab)
Lidocaine label
Version not recorded · Effective date not recorded
Distribution: When lidocaine is administered intravenously to healthy volunteers, the volume of distribution is 0.7 to 2.7 L/kg (mean 1.5 ± 0.6 SD, n=15).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:1d28d687-695e-4cd9-97e2-7d4fdab9772a (opens source in a new tab)
Lidocaine label
Version not recorded · Effective date not recorded
Distribution: When lidocaine is administered intravenously to healthy volunteers, the volume of distribution is 0.7 to 2.7 L/kg (mean 1.5 ± 0.6 SD, n=15).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:85e72943-6989-42f4-b519-a3ebbf4bc777 (opens source in a new tab)
Lidocaine label
Version not recorded · Effective date not recorded
Figure 1: Mean lidocaine blood concentrations after three consecutive daily applications of three lidocaine patches simultaneously for 12 hours per day in healthy volunteers (n = 15). image description Distribution: When lidocaine is administered intravenously to healthy volunteers, the volume of distribution is 0.7 to 2.7 L/kg (mean 1.5 ± 0.6 SD, n = 15).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:4d04052c-3e0a-469a-9265-99604f13e507 (opens source in a new tab)
Lidocaine label
Version not recorded · Effective date not recorded
Figure 1 Mean lidocaine blood concentrations after three consecutive daily applications of three lidocaine patches simultaneously for 12 hours per day in healthy volunteers (n = 15). 1 Distribution: When lidocaine is administered intravenously to healthy volunteers, the volume of distribution is 0.7 to 2.7 L/kg (mean 1.5 ± 0.6 SD, n=15).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:2ce8a4fe-8aa6-4dc5-ad0f-3984ae68c4bc (opens source in a new tab)
Lidocaine label
Version not recorded · Effective date not recorded
Figure 1 Distribution When lidocaine is administered intravenously to healthy volunteers, the volume of distribution is 0.7 to 2.7 L/kg (mean 1.5 ± 0.6 SD, n=15).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:9b47102e-3b35-4aa7-a380-cd02ba9eac65 (opens source in a new tab)
Lidocaine label
Version not recorded · Effective date not recorded
Figure 1 Distribution When lidocaine is administered intravenously to healthy volunteers, the volume of distribution is 0.7 to 2.7 L/kg (mean 1.5 ± 0.6 SD, n=15).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:a575bcb8-478f-1f7e-e053-2995a90a4b12 (opens source in a new tab)
Lidocaine label
Version not recorded · Effective date not recorded
Figure 1 Mean lidocaine blood concentrations after three consecutive daily applications of three LIDOCAINE PATCH 5% patches simultaneously for 12 hours per day in healthy volunteers (n = 15). [Figure 1] Distribution When lidocaine is administered intravenously to healthy volunteers, the volume of distribution is 0.7 to 2.7 L/kg (mean 1.5 ± 0.6 SD, n=15).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:0bef12dd-6cea-d12b-e063-6394a90a002e (opens source in a new tab)
Lidocaine label
Version not recorded · Effective date not recorded
Figure 1 Distribution When lidocaine is administered intravenously to healthy volunteers, the volume of distribution is 0.7 to 2.7 L/kg (mean 1.5 ± 0.6 SD, n=15).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f20ab860-e49a-4f3f-868e-6a60780af5a7 (opens source in a new tab)
Lidocaine label
Version not recorded · Effective date not recorded
Figure 1 Distribution When lidocaine is administered intravenously to healthy volunteers, the volume of distribution is 0.7 to 2.7 L/kg (mean 1.5 ± 0.6 SD, n=15).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:1112681c-8de7-472b-8db4-2702054b835b (opens source in a new tab)
Lidocaine label
Version not recorded · Effective date not recorded
Distribution When lidocaine is administered intravenously to healthy volunteers, the volume of distribution is 0.7 to 2.7 L/kg (mean 1.5 ± 0.6 SD, n = 15).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:56a54ef4-7aa0-e181-e063-6394a90a3e0e (opens source in a new tab)
Lidocaine label
Version not recorded · Effective date not recorded
Distribution When lidocaine is administered intravenously to healthy volunteers, the volume of distribution is 0.7 to 2.7 L/kg (mean 1.5 ± 0.6 SD, n = 15).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:032b37a7-8a47-4809-a330-c76314225cbd (opens source in a new tab)
Lidocaine label
Version not recorded · Effective date not recorded
Figure 1 Distribution When lidocaine is administered intravenously to healthy volunteers, the volume of distribution is 0.7 to 2.7 L/kg (mean 1.5 ± 0.6 SD, n=15).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:fa69dfdf-ab73-48a9-944d-25e88d7766df (opens source in a new tab)
Lidocaine label
Version not recorded · Effective date not recorded
Figure 1 Distribution When lidocaine is administered intravenously to healthy volunteers, the volume of distribution is 0.7 to 2.7 L/kg (mean 1.5 ± 0.6 SD, n=15).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:82bb7767-5407-4593-b6d4-90859890e376 (opens source in a new tab)
Lidocaine label
Version not recorded · Effective date not recorded
Distribution When lidocaine is administered intravenously to healthy volunteers, the volume of distribution is 0.7 to 2.7 L/kg (mean 1.5 ± 0.6 SD, n = 15).
Projected row 860
- Medicine slug
- linagliptin
- Compared field
- bioavailability
- Comparison state
- agree
- Reason codes
- COMPATIBLE_VALUES_OVERLAP
- Documents examined
- 3
- Source count
- 3
- Agreement rate
- 1
- Recorded readings
30%
- Numeric value
- 30
- Unit
- %
- Source records
- 3
Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.
Show all 3 source records
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:b1da67d4-51e0-41b7-9fe1-7f38c0d1baa1 (opens source in a new tab)
Linagliptin label
Version not recorded · Effective date not recorded
Absorption The absolute bioavailability of linagliptin is approximately 30%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:c797ea5c-cab7-494b-9044-27eba0cfe40f (opens source in a new tab)
Linagliptin label
Version not recorded · Effective date not recorded
Absorption The absolute bioavailability of linagliptin is approximately 30%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:dfe327e8-f6ab-41e5-bdef-d520118cd83a (opens source in a new tab)
Linagliptin label
Version not recorded · Effective date not recorded
Absorption The absolute bioavailability of linagliptin is approximately 30%.
Access
Query or download the projection
GET /api/datasets/source-consensus?limit=10&offset=850Allowed query parameters
- q
- Case-insensitive text search over the public fields named for this dataset.
- state
- Exact comparability state.Values: agree, differ, not_comparable, insufficient_context
- field
- Exact recorded field key.Values: bioavailability, halfLife, proteinBinding, tMax, volumeOfDistribution
- limit / offset
- Pagination is required. limit is at most 200; offset is bounded. Set format=csv for the same projected page as a download.
Reuse and corrections
Keep the boundary attached
CC BY 4.0 applies to RNAWiki licenses its selection, schema, structure, and derived projection. Quoted source passages and third-party records retain their original rights.
Cite RNAWiki, this dataset identifier, and the generated date. Keep the “does not mean” statement with any downstream display so a corpus measurement is not mistaken for medical advice.